Prof.Dr. İBRAHİM YILDIZ

Evaluation of c-kit (CD 117) expression as a prognostic factor in testicular germ cell tumors: An Izmir Oncology Group (IZOG) study.

J BUON. 2015 Jul-Aug;20(4):1054-60 Salman T, Yildiz E, Yildiz I, Yavuzer D, Unlu M, Varol U, Akyol M, Yildiz Y, Bayoglu V, Kucukzeybek Y, Alacacioglu A

Quality of life in colorectal cancer patients: an Izmir Oncology Group (IZOG) study.

J BUON. 2015 Jul-Aug;20(4):1015-22. Akyol M, Ulger E, Alacacioglu A, Kucukzeybek Y, Bayoglu V, Yildiz Y, Yildiz I, Salman T, Varol U, Demir L, Dirican A, Gumus Z, Oktay Tarhan M.

First-line cisplatin plus bolus 5- Fluorouracil combination in patients with locally advanced and metastatic esophageal cancer (Izmir Oncology Group study)

Ahmet Alacacıoğlu, Mustafa Oktay Tarhan. Acta Oncol Tur. 2015; 48(1): 20-26 DOI: 10.5505/aot.2015.92408 Murat Akyol, Yüksel Küçükzeybek, Umut Varol, Ibrahim Yıldız, Suna Çokmert, İbrahim Vedat Bayoğlu, Yaşar Yıldız, Lutfiye Demir, Alper Can, Ahmet Dirican